Allantoin is not carcinogenic. It has no classification as a carcinogen from any major regulatory or health agency, and the available safety data show no evidence that it causes cancer or damages DNA. If you’ve seen this ingredient on a product label and felt a moment of concern, the short answer is that allantoin is one of the most thoroughly vetted and widely permitted ingredients in skincare.
What Major Agencies Say
The International Agency for Research on Cancer (IARC), which maintains the most widely referenced classification system for carcinogens, does not list allantoin as a carcinogen in any group. It simply has no indication of carcinogenicity to humans.
The U.S. FDA recognizes allantoin as “generally recognized as safe and effective” for use as an over-the-counter skin protectant at concentrations of 0.5% to 2%. That designation means the FDA reviewed the safety evidence and found no meaningful risk at those levels. The Cosmetic Ingredient Review (CIR) Expert Panel, an independent body that evaluates cosmetic ingredient safety, also concluded that allantoin and its related complexes are safe in the product categories and concentrations currently in use. At the time of their final safety report, allantoin appeared in over 1,376 cosmetic products at concentrations up to 2%.
No Evidence of DNA Damage
Cancer begins when something damages DNA in a way that causes cells to grow uncontrollably. One of the first steps in evaluating whether a substance could be carcinogenic is testing whether it causes genetic mutations or chromosomal damage. These genotoxicity tests are a standard screening tool: if a substance passes them cleanly, it lacks the basic mechanism most chemical carcinogens use.
Allantoin-containing extracts have been put through the major genotoxicity battery. In Ames tests, which expose multiple bacterial strains to a substance to see if it triggers gene mutations, allantoin-containing preparations produced no increase in mutant colonies at any dose, with or without metabolic activation (a step that simulates how the liver might chemically transform the substance). In chromosomal aberration tests using hamster lung cells, there was no significant or dose-related increase in structural or numerical chromosome damage compared to controls. In vivo micronucleus tests, which look for chromosome breakage in living animals, also came back clearly negative.
Taken together, these results mean allantoin does not appear to damage DNA through any of the standard pathways scientists look for.
How Your Body Handles Allantoin
Allantoin is not a synthetic chemical invented for skincare. It is a natural byproduct of purine metabolism, the process your body uses to break down certain components of DNA and RNA. In most mammals, an enzyme called uricase converts uric acid into allantoin, which is water-soluble and easy to excrete. Humans lost the functional version of that enzyme through evolutionary mutations, which is why we accumulate uric acid instead. But allantoin still circulates in the human body at low levels and is a recognized part of normal biochemistry.
Because allantoin is a small, water-soluble molecule that the body already knows how to process, it does not bioaccumulate or build up in tissues the way some synthetic chemicals can. When applied to the skin in a lotion or cream, it works primarily at the skin’s surface to soothe irritation and support the skin barrier.
Typical Concentrations in Products
Most cosmetic formulations use allantoin at 0.1% to 0.5%. Therapeutic over-the-counter products, like medicated skin protectants, go up to 2%, which is also the FDA’s approved ceiling for OTC use. These are low concentrations, and they fall well within the range the CIR panel and FDA reviewed when concluding the ingredient is safe.
You’ll find allantoin in moisturizers, sunscreens, lip balms, baby care products, shaving creams, and wound-healing ointments. Its primary job is calming irritated skin and promoting cell turnover in the outermost skin layer. It has been used in commercial formulations for decades, giving regulators a long track record of real-world safety data to draw from.
Why the Question Comes Up
People often search for whether a cosmetic ingredient is carcinogenic after seeing it on a label and not recognizing the name. Chemical-sounding names can trigger reasonable caution, especially when ingredients like formaldehyde releasers or certain UV filters have genuinely raised safety concerns in recent years. But not every unfamiliar ingredient carries risk, and allantoin is a case where the safety evidence is consistent and reassuring across multiple independent reviews. No regulatory body, expert panel, or body of genotoxicity research has identified a cancer concern with this ingredient.